Skip to main content
. 2024 May 8;15(5):596. doi: 10.3390/genes15050596

Table 2.

Characteristics of the study population.

Characteristic All Patients
(n = 126)
Infected
(n = 59)
Non-Infected
(n = 67)
P
Sex (M:F) 62:64 34:25 28:39 0.08 b
BMI a 28.0
(24.6–30.2)
29.4
(25.4–32.0)
26.8
(24.7–29.5)
0.10 c
CCI 0: 7 pts (5.6%) 0: 5 pts (8.5%) 0: 2 pts (3%) 0.29 b
1: 16 pts (12.7%) 1: 8 pts (13.6%) 1: 8 pts (12%)
2: 35 pts (27.8%) 2: 19 pts (32.2%) 2: 16 pts (24%)
3: 33 pts (26.2%) 3: 10 pts (17%) 3: 23 pts (34.3%)
4: 16 pts (12.7%) 4: 7 pts (11.9%) 4: 9 pts (13.4%)
5: 9 pts (7.1%) 5: 3 pts (5.0%) 5: 6 pts (9%)
6: 3 pts (2.4%) 6: 2 pts (3.4%) 6: 1 pts (1.5%)
ASA score 1: 27 pts (21.4%) 1: 17 pts (28.8%) 1: 10 pts (15%) 0.05 b
2: 64 pts (50.8%) 2: 23 pts (39%) 2: 41 pts (61.2%)
3: 28 pts (22.2%) 3: 14 pts (23.7%) 3: 14 pts (20.9%)
Age at surgery a 68 (60–75) 70 (61.5–76) 66 (57–74) 0.17 c

a Age in years; median and IQR. b Chi-square. c Mann–Whitney. BMI, body mass index. M, male; F, female. CCI, Charlson Comorbidity Index. ASA, American Society of Anesthesiologists. CCI and ASA score were not available for 7 patients, including 5 infected and 2 non-infected subjects.